Venture Visionary Partners’s Charles River Laboratories CRL Stock Holding History

Venture Visionary Partners’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3,434	Closed	-$673K	–	540
2023 Q3	$673K	Sell	3,434 -1,189	-26%	-$244K	0.04%	286
2023 Q2	$972K	Buy	4,623 +2	+0%	+$398	0.06%	248
2023 Q1	$933K	Buy	4,621 +1,212	+36%	+$275K	0.06%	251
2022 Q4	$743K	Buy	+3,409	New	+$744K	0.05%	257
2022 Q3	–	Sell	-536	Closed	-$115K	–	694
2022 Q2	$115K	Buy	+536	New	+$131K	0.01%	569
2022 Q1	–	Sell	-553	Closed	-$208K	–	511
2021 Q4	$208K	Buy	553 +9	+2%	+$3.5K	0.01%	484
2021 Q3	$224K	Buy	+544	New	+$226K	0.02%	463

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Meritage Group San Francisco, California $2.6B AUM 15.71% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Venture Visionary Partners's CRL Position: Q4 2023 in Review

Venture Visionary Partners sold out of Charles River Laboratories (CRL) in Q4 2023, closing a stake of 3,434 shares — an estimated $673K sold.

Venture Visionary Partners first reported a position in CRL in Q3 2021 and held it in 7 quarters. The position peaked at $972K in Q2 2023. 634 funds tracked by Wall St. Rank hold CRL as of Q4 2023.

Venture Visionary Partners reported no remaining Charles River Laboratories position as of Q4 2023 after selling out during the quarter.
Venture Visionary Partners sold 3,434 Charles River Laboratories shares in Q4 2023, an estimated $673K.
Venture Visionary Partners first reported a position in Charles River Laboratories in Q3 2021 and held it in 7 quarters.
Venture Visionary Partners's Charles River Laboratories position peaked at $972K in Q2 2023.
634 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2023.

Based on Venture Visionary Partners's 13F filing for Q4 2023, filed 24 Jan 2024.